Whole-genome sequencing of spermatocytic tumors provides insights into the mutational processes operating in the male germline por Giannoulatou, E, Maher, G, Ding, Z, Gillis, A, Dorssers, L, Hoischen, A, Rajpert-De Meyts, E, WGS500 Consortium, McVean, G, Wilkie, A, Looijenga, L, Goriely, A

Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline. por Giannoulatou, E, McVean, G, Taylor, I, McGowan, S, Maher, G, Iqbal, Z, Pfeifer, S, Turner, I, Burkitt Wright, E, Shorto, J, Itani, A, Turner, K, Gregory, L, Buck, D, Rajpert-De Meyts, E, Looijenga, L, Kerr, B, Wilkie, A, Goriely, A

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. por Sturgeon, C, Duffy, M, Stenman, U, Lilja, H, Brünner, N, Chan, D, Babaian, R, Bast, R, Dowell, B, Esteva, F, Haglund, C, Harbeck, N, Hayes, D, Holten-Andersen, M, Klee, G, Lamerz, R, Looijenga, L, Molina, R, Nielsen, H, Rittenhouse, H, Semjonow, A, Shih, I, Sibley, P, Sölétormos, G, Stephan, C